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【Abstract】Objective:    To evaluate the effect of the
treatment modality guided by intraventricular intracranial
pressure (ICP) monitoring on patients with severe traumatic
brain injury (TBI).
Methods:    The clinical data of a group of 136 severely
brain-injured patients admitted to Shanghai Neurosurgical
Emergency Center from December 2004 to February 2006
were studied.
Results:    The intraventricular ICP monitor was placed
in all the 136 patients via Kocher’s pathway, Paine’s path-
way or intraoperative opened ventricle. In this series, the
probe was placed during the procedure of craniotomy in 98
patients; for other 38 patients, the probe was placed initially
to measure or to monitor ICP. A stepwise protocol targeting
at ICP control (≤20 mm Hg) and optimal cerebral perfusion
pressure (CPP)  maintenance (60-90 mm Hg) was deployed.
Management of patients with severe traumatic brain
injury guided by intraventricular intracranial pressure
monitoring: a report of 136 cases
ZENG Tao 曾涛 and GAO Liang 高亮*
Among them, 76 patients survived with good recovery, 14
with moderate disability, 24 with severe disability, 10 with
vegetative state, and 12 died. Complications associated with
intraventricular ICP monitoring included hemorrhage and
infection. Hemorrhage occurred in 1 patient and infection in
5 patients. There were no unacceptable complications re-
lated to ICP monitoring.
Conclusions:    Ventricular access for ICP monitoring
can be safely and accurately achieved. ICP monitoring via
ventriculostomy may facilitate an early and accurate inter-
vention for severely brain-injured patients. The intraven-
tricular ICP monitoring is a low-risk procedure and can yield
great benefits for management of patients with severe TBI.
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The impact of traumatic brain injury (TBI) on hu-man lives is staggering. It is the leading causeof death and disability after serious injuries. In-
tracranial hypertension (ICH)  may occur in 70% of brain-
injured patients, and is responsible for a substantial
proportion of TBI-related deaths.1 Therefore, controlling
intracranial pressure (ICP) is paramount in the man-
agement of severe TBI. To this end, the notion of ICP
monitoring and ICP-targeted procedures have been rec-
ommended as guidelines for management of severe
brain-injured patients.2-4 Intraventricular route is regarded
as the optimal approach for ICP monitoring and it en-
ables therapeutic cerebrospinal fluid (CSF) drainage for
control of ICP. In this clinical report, we described our
experience of a progressive management protocol
guided by intraventricular ICP monitoring in 136 patients
with severe TBI.
METHODS
Demographic characteristics of patients
 Patients with severe TBI admitted from December
2004 to February 2006 were considered for inclusion in
the study. Of the 136 patients with severe brain injury,
defined as an initial Glasgow coma scale (GCS) score
≤ 8 in the emergency room, 91 were male aged be-
tween 16-78 years (mean 43.5 years), 45 were female
aged between 17-78 years (mean 47.5 years). Among
them, 92 patients suffered from motor vehicle crashes,
17 from falling accidents and 11 from pedestrian falling
accidents, and 16 patients were struck by or against
an object. On admission to the neuro-intensive care
unit (NICU), 78 patients were classified as GCS 6-8, 58
as 3-5, 64 patients had single dilated pupil, and 29 pa-
tients had bilateral dilated pupils. According to major
characteristics of computed tomography (CT) on
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admission, 11 patients had epidural hematoma, 51 had
subdural hematoma accompanied by cerebral contu-
sion and laceration, 25 had intracerebral hematoma,
and 16 had multiple intracranial mass lesions. There
were 33 cases of diffuse axonal injuries or primary brain
stem injuries, and 57 of complicated multiple system
injuries.
Placement of intraventricular ICP probes
Twelve patients were inserted with the probes made
in Camino, USA, and the others with probes from
Codaman, USA, both with closed CSF drainage devices.
Normal coagulation conditions were prerequisite for the
intraventricular probe implantation surgeries. Probes
were implanted in operating rooms by qualified
neurosurgeons. The pathway for ventricle cannulation
was determined by comprehensive consideration of in-
tracranial mass lesions, integrity of head skin coverage,
configuration of the skull fractures and possible future
invasive procedures. In an ambivalent situation, the right
side was selected. There were three commonly used
pathways for the ventricular cannulation: the frontal burr
hole (Kocher’s pathway), the Paine’s pathway or the
opened ventricle during craniotomy. The indwelling pe-
riod for the intraventricular probe was usually no more
than 7 days. Prophylactic intravenous antibiotics were
administered during monitoring.
Basic management in NICU
Each patient was fully resuscitated, and airway pro-
tected by endotracheal intubations or tracheostomy, with
head side of the bed elevated approximately 20°-30° if
there was no contraindication. All patients received ind-
welling catheter via central vein and the central venous
pressures (CVP) were monitored. Our early management
for head-injured patients emphasized prevention and
correction measures. We strived to maintain euvolemia,
euglycemia, normothermia and to avoid moderate or
severe anemia. Agitated patients were given intravenous
fentanyl and/or propofol or midazolam infusion for seda-
tion and analgesia. Muscular relaxant, usually vecuron,
was administrated to those who were resistant to me-
chanical ventilation, with severe decerebrate rigidity or
refractory epileptic status. Antiepileptic drugs were ad-
ministrated for 7 days after injuries. Coagulopathic states
were rigorously reversed through use of blood and plasma
products. Early enteral nutritional support was instituted
within 72 hours after injuries. Major basic treatment goals
in NICU are listed in Table 1.
Table 1. Goals in neurosurgical intensive care treatment
Variables                                                         Goals
Systolic blood pressure                          ≥ 100 mm Hg
Central venous pressure                           5-12 mm Hg
PaCO2                                                       30-35 mm Hg
PaO2                                             ≥ 75 mm Hg
SaO2                                           ≥ 93%
Blood glucose                                         4.4-7.8 mmol/L
Temperature                                   ≤ 38 °C
Hemoglobin                                  ≥ 90 g/L
Treatment strategies guided by ICP monitoring
Stepwise ICP management protocol guided by
ICP monitoring    All the patients were monitored with
persistent intraventricular drainage. When ICP became
elevated despite rigorous basic management and CSF
drainage, defined as a level greater than 20 mm Hg (15
mm Hg for patients with decompressive bony defect
area≥5 cm×5 cm) for more than 5 minutes,
osmotherapy was initiated. Initially, a bolus of mannitol
(0.25-0.5 g/kg) was administrated. Additional mannitol
boluses were administered if ICP remained elevated
despite these measures, until a maximal serum osmo-
larity of 320 mmol/L was reached. Other osmotic or
diuretic agents such as glycerol fructose, albumin, lasix
could be conditionally used as an adjuvant or alternative.
As a second-tier therapy, hyperventilation might be tem-
porarily applied only for abrupt ICP elevations or im-
pending cerebral herniation rather than routine or pro-
phylactic application. Ventilation parameters were op-
timized according to blood-gas parameters to ensure
PaCO2 above 30 mm Hg all the time. Mild hypothermia
therapy was induced to maintain rectal temperature at
32°C-35°C .When refractory ICH persisted without sur-
gically amenable lesions in repetitive CT scans, the
failure of medical treatment and deterioration of patients
mandated timely surgical intervention like decompres-
sive craniecotmy or even lobectomy. When malignant
ICH persisted despite aggressive management, barbi-
turate coma (usually phenobarbital) treatment was
initiated. Upon each escalation of ICP treatment, the
occurrence of enlarged mass lesions or other lesion
indicating surgical intervention was excluded by repeti-
tive CT scan.
Determination of surgical intervention    In cer-
tain circumstances where surgical indication was
equivocal, the value of ICP might serve as a reference.
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An initial ICP≥30 mm Hg for more than 15 minutes
was considered as a surgical indication to remove the
intracranial mass lesions immediately. Otherwise, the
patients could be treated conservatively under the guid-
ance of ICP monitoring, and if persistently elevated ICP
refractory to systemic therapies were observed during
subsequent monitoring, craniotomy to remove mass le-
sions or bony decompression was taken into
consideration.
Maintenance of optimal cerebral perfusion
pressure (CPP)    ICP is an important determinant of
cerebral perfusion pressure (CPP=MAP–ICP). Optimal
CPP maintenance was conducted with the guidance of
ICP monitoring. The aim is to keep CPP at 60-90 mm Hg.
Prevention of hypovolemia and hypotension was required
to achieve optimal mean arterial pressure (MAP). In
normal circumstances, ICP-reducing treatment was pri-
mary measures in the maintenance of CPP. In cases
where ICP was particularly high or signs of cerebral
ischemia appeared, vasopressors were cautiously ad-
ministrated to raise the MAP, thus optimal cerebral
perfusion pressure could be maintained.
RESULTS
Implantation of ICP monitoring probes
Ninety-eight probes were inserted during surgical
procedures for evacuation of intracranial mass lesions.
Probes were implanted ipsilaterally to the operative side
in 52 patients (via Kocher’s pathway in 8 patients, via
Paine’s pathway in 32, and via the opened ventricle in
12). In the rest of 46 cases, contralateral side was cho-
sen (via Kocher’s point). Probes in 38 patients were
placed initially or solely for ICP monitoring purpose. All
the 38 probes were inserted via Kocher’s pathway, 13
in the left, and the other 25 in the right. A one-off suc-
cessful ventriculostomy was achieved in most patients,
except that two or more passes were needed to achieve
ventricular entry in 5 patients (Figure 1). The intraven-
tricular probes were kept inside for 4 days in 4 patients,
5-7 days in 132 patients, and 8-9 days in 2 patients.
ICP monitoring-directed managements
All the patients were monitored with persistent CSF
drainage, varying in volume from 30 ml/d to 300 ml/d. In
this series, 124 patients were prescribed intravenous
mannitol of 0.25-0.5 g/kg, while 12 patients did not re-
ceive mannitol infusion due to lack of evidence of ICH.
Mild hyperventilation was applied in 37 of 68 patients
receiving mechanical ventilation. Mild hypothermia was
induced using ice-blanket in 11 patients with intractable
fever. Based on measurements from ICP monitoring,
craniotomy was performed in 39 patients, immediately
upon the verification of initial ICP higher than 30 mm Hg
in 8 patients and during ICP monitoring in 31 patients,
either due to delayed intracranial hematoma or signifi-
cant cerebral edema or swelling. Of these 31 patients,
bony decompression procedures were performed in 20
patients, bifrontal craniectomy in 4 patients and de-
compressive frontal-temporal-parietal hemicraniectomy
in 16 patients. Decompressive lobectomy was performed
in 9 patients who had already experienced bony de-
compression for further controls of intractable ICH. One
patient underwent 3 surgical procedures during ICP
monitoring: the first for evacuation of delayed epidural
hematoma, the second for bony decompression and
the last for decompressive lobectomy. Barbiturate coma
therapy was induced in two patients with refractory ICH
accompanied by epileptic status.
Major complications related to intraventricular ICP
monitoring
Intracranial infections    ICP monitoring-related
intracranial infections were diagnosed if CSF samples
from ventricular drainage were found bacteria-positive
or persistent inflammatory cells (>50% polymorpho-
nuclear leucocytes) and abnormal biochemical param-
eter (glucose <0.83 mmol/L). Five patients (3.7%) de-
veloped intracranial infections. Klebsiella pneumoniae
was identified by CSF cultures from 2 patients. Infec-
tions were controlled in all patients through systematic
and intrathecal administration of sensitive antibiotics
and removal of the intraventricular devices.
Intracranial hemorrhage    Intracranial bleeding
attributable to ICP monitoring was defined as new hem-
orrhage area surrounding the probes demonstrated by
postoperative CT scans. Only one patient (0.7%) was
found having fresh bleeding surrounding the catheter.
Without occupational effects, no surgical intervention
was necessary; neither did the patient show any new
focal neurological defects.
Outcomes of patients with severe TBI
Assessment of patients’ extended Glasgow out-
come score (GOS) was carried out more than 6 months
after the injuries (average 8.7 months). Five of 121 pa-
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tients received CSF peritoneal shunt due to that post-
traumatic hydroencephalus were followed up longer than
Table 2. Treatment outcome of patients with severe traumatic brain injury
GCS (on admission)         n
              GOS (6 months)
Good recovery          Moderate disability         Severe disability           Vegetative status           Death
          6-8                   78                  54                                   8                                10                                    3                             3
               3-5                   58                  22                                   6                                14                                    7                             9
DISCUSSION
Treatment for severe TBI has been focused on con-
trol of ICP and prevention of secondary insults to the
brain. The tiered ICP management protocol is intended
to achieve optimal ICP with minimal interventions, for
every ICP treatment has a potential deleterious side
effect. It is unnecessary to initiate ICP control mea-
sures in the absence of ICH, or to escalate to the next
tier measures when ICP could be effectively controlled
through measures in previous tier. As the basic mea-
sures of the ICP management, a position with head
elevated approximately 20°-30° would facilitate the
venous reflux without exacerbating cerebral ischemia.
Moderate sedation, analgesia and muscle relaxation
treatment with a secure airway may facilitate decreas-
ing ICP directly or indirectly by mitigating secondary
damages. Conditions like hyperthermia, hypercapnia,
or hyperglycemia are considered as secondary brain
injury factors (SBIFs),5 which not only complicate the
NICU management, but also consequently contribute
to elevation of ICP. Measures to maintain homeostasis
and to prevent SBIFs are emphasized.
In this report, all patients were monitored with closed
continuous CSF drainage. Upon deploying external drain-
age of CSF, we usually set the external device 20 cm
above the level of the external auditory meatus, not only
1 year. The outcomes are summarized in Table 2.
Figure 1. A: An intraventricular ICP monitor in-
serted contralaterally to the operative side via a
frontal burr hole (Kocher’s pathway). B: An intra-
ventricular probe placed ipsilaterally to the opera-
tive side via Paine’s approach during the proce-
dure of frontal-temporal craniotomy. C: An ICP
probe placed in the opened temporal horn of the
ventricle during the procedure of the evacuation
of hematoma in the temporal lobe. Figure 2. A:  A
27-year-old patient with severe TBI showing uni-
lateral dilated pupil scored 6 in GCS scale. An
initial CT scan depicted a right temporal extradural
hematoma and left front-temporal contusion and
laceration. B: An immediate craniotomy was per-
formed to remove the extradural hematoma and
the bone flap was discarded. An intraventricular
ICP probe was inserted via left frontal burr hole.
The postoperative ICP remained high and refrac-
tory to conservative treatments. C, D, and E: A
repeated CT scan showed a large low-density
area in temporal-occipital lobe (white arrow) and
patchy low-density areas in parietal-occipital lobe
(white arrows). F: A craniotomy on the contralat-
eral side for the evacuation of the lacerated brain
tissue and bony decompression was performed.
The CT scan two weeks later showed ameliora-
tion of low density area and the patient survived
with satisfying recovery.
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to reduce ICP by draining CSF smoothly, but also to
maintain control over intracranial dynamics and to avoid
incorrect ICP measurements due to over-drainage-in-
duced collapsed ventricles.6 According to Monroe-Kellie
doctrine, it is believed that in the setting of ICH, by
reducing CSF volume, ICP decreases dramatically and
thus cerebral perfusion improves. Meanwhile, it could
afford additional benefit by depleting bloody CSF to
mitigate vasospasm and nerve root stimuli and to re-
duce incidence of posttraumatic hydroencephalus later
on.7 If ICP remains elevated despite moderate basic
treatment and CSF drainage, the first-tier treatment
should be initiated. Several criteria for ICP treatment
threshold were proposed.8-10 We believe that 20 mm Hg
(or 15 mm Hg in those with decompressive bone area >
5 cm×5 cm) should be regarded as the threshold to
institute ICP control treatments. Mannitol is the most
commonly used osmotic agent. We emphasize man-
nitol as a therapeutic rather than prophylactic agent
and it should be administrated and weaned according
to ICP and serum osmolaity because if administrated
excessively, it would result in iatrogenic insults such
as circulative overload or insufficiency, disturbance of
water and electrolyte balance. Whereas insufficient de-
hydration therapies may lead to a vicious circle of el-
evated ICP and poor CPP, result in increased mobility
and mortality. The maximum serum osmolality during
mannitol therapy is 320 mmol/L, a threshold where higher
doses of mannitol would greatly increase the possibilities
of renal failure without additional effects on lowering ICP.
The second-tier treatments, hyperventilation and
hypothermia, are not used as routine. If needed, venti-
lation should be adjusted to maintain PaCO2 at approxi-
mately 30-35 mm Hg to prevent vasoconstriction and
consequently insufficient cerebral perfusion. In hiber-
nation therapy, body temperature should be adjusted
between 32°C and 35°C to minimize potential damage
to the cardiovascular system. Decompressive craniec-
tomy or even lobectomy for medically refractory ICH is
usually life-saving measures. In this report, decompres-
sive lobectomy was performed in 9 patients, in whom 2
patients survived in vegetative status and the other 7
did better. In our stepwise protocol, decompressive
surgical intervention was preferred to barbiturate coma
therapy. Barbital therapy should only be conducted cau-
tiously under electroencephalographic monitoring in
patients with stable circulative status. Myriad adverse
effects such as significant hypotension and defects in
neurological assessments limit its use. The barbitu-
rate therapy is set at the apex of pyramid in author’s
algorithm.
Additional concern about CPP monitoring is raised
from ICP monitoring. It is crucial that adequate CPP,
an indicator for brain perfusion, is maintained, as
hypoperfusion being a main contributor to the develop-
ment of secondary cerebral ischemic injuries and to
poor prognosis. Appropriate CPP can not only keep
adequate brain perfusion, but also maintain optimal
capillary hydrostatic pressure and then facilitate ab-
sorption of edematous fluids. The actual threshold of
CPP may vary among patients due to their unique in-
jury patterns. So the ideal CPP target is stil l
controversial. We recommended an optimal CPP level
between 60 mm Hg and 90 mm Hg. By ensuring CPP,
some ischemic lesion could be reversed. Avoiding hy-
povolemia and hypotension are the premise of optimal
MAP. It is helpful to have large-bore intravenous
cannulas, preferably central lines, placed for rapid in-
fusing of f luids and/or vasopressors in case of
hypotension. Monitoring of CVP as a volume indicator
is also necessary for maintaining euvolemia.
Moreover, ICP monitoring is crucial for patients with
severe TBI, whereas their neurological or radiological
conditions are difficult to be regularly assessed because
of therapeutic sedation or mechanical ventilation. In these
scenarios, ICP monitoring can compensate the absence
of neurological or radiological assessments. In clinical
practice, sometimes ambiguous situations would make
doctors really difficult to make deliberate decisions just
according to neurological and/or radiological evaluation.
Furthermore, elevation of ICP might precede the radio-
logical and clinical deterioration. The trend of ICP el-
evation can help neurosurgeons to make timely diag-
nostic and treatment decisions. With ICP monitoring,
individualized and rational decisions of treatment could
be made accordingly. Thus patients with indications of
craniotomy or decompression can undergo surgical
procedure swiftly, while those who do not need surgery
can be treated with minimum cost.
However, ventricular access is thought to be diffi-
cult because there is potential compression or shift of
ventricles. According to our experience, insertion of an
intraventricular probe is a relatively simple and straight-
forward procedure. In most cases, a ventricular probe
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can be safely placed in position by a qualif ied
neurosurgeon. Rarely are neuronavigation or ultrasonog-
raphy needed. Hemorrhage and infections are major
complications related to ICP monitoring. Significant
hematomas requiring surgical evacuation occurred in
0.5% of patients in a report with more than 200 pa-
tients receiving ICP monitoring.11 In our report, hemor-
rhage was confirmed in 1 out of 136 patients (0.7%)
about 5 ml in volume by postoperative CT scan along
with catheter tracking, not indicating any surgical
intervention. The incidence of ventricular catheter-related
intracranial infection was 3.7% in this report, similar to
previous reports.12,13 Other potential complications such
as malposition, breakage, and dislodgement of probes
can be avoided by proper training, practice, and careful
execution. In the authors’ experience, serious compli-
cations associated with intraventricular devices are clini-
cally rare and should not deter the application of ICP
monitoring.
   Obviously, ICP monitors could not show the whole
picture during monitoring and management of severely
brain-injured patients. But by monitoring ICP, the
initiation, escalation and weaning of ICP management
can be conducted accordingly. ICP monitoring and ICP
guided treatments are helpful for early warning and sub-
sequent reasonable management of impending second-
ary brain injuries, and for optimizing cerebral perfusion
pressure. Furthermore, the intraventricular catheter may
provide additional therapeutic route by draining CSF. In
summary, the intraventricular ICP monitoring is a low-
risk procedure but yields great benefits for manage-
ment of severe TBI patients.
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